Bruno Fernandes

Bruno Fernandes

Auto-generated profile, based on publicly available information

Bruno Fernandes

B's Research Group, I3Bs - Research Institute on Biomaterials, Biodegradables and Biomimetics, University of Minho, Headquarters of the European Institute of Excellence on Tissue Engineering and Regenerative Medicine, AvePark, Parque de Ciência E Tecnologia, Zona Industrial da Gandra, 4805-694 Barco, Guimarães, Portugal; ICVS/3B's - PT Government Associated Laboratory, Portugal

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 October 2016 in Pigment Cell & Melanoma Research
Verified
Journal Article
Closed access
PDF file
BFBruno Fernandes
Bruno Fernandes
Teresa MatamáTeresa Matamá
Teresa Matamá
DGDiana Guimarães
Diana Guimarães
Andreia Castro GomesAndreia Castro Gomes
Andreia Castro Gomes
Artur Cavaco-PauloArtur Cavaco-Paulo
Artur Cavaco-Paulo

29 January 2015 in International Journal of Cosmetic Science
Verified
Journal Article
Closed access
PDF file
BFB. Fernandes
B. Fernandes
RSR. Silva
R. Silva
Artur RibeiroArtur Ribeiro
Artur Ribeiro
Teresa MatamáTeresa Matamá
Teresa Matamá
Andreia Castro GomesAndreia Castro Gomes
Andreia Castro Gomes
Artur Cavaco-PauloArtur Cavaco-Paulo
Artur Cavaco-Paulo

13 November 2023 in Journal of Advanced Research
Verified
Journal Article
Open access
Teresa MatamáTeresa Matamá
Teresa Matamá
CCCristiana Costa
Cristiana Costa
BFBruno Fernandes
Bruno Fernandes
RARita Araújo
Rita Araújo
CCCelia F. Cruz
Celia F. Cruz
Artur Cavaco-PauloArtur Cavaco-Paulo
Artur Cavaco-Paulo
Introduction: Natural hair curvature and colour are genetically determined human traits, that we intentionally change by applying thermal and chemical treatments to the fibre. Presently, those cosmetic methodologies act externally and their recurrent use is quite detrimental to hair fibre quality and even to our health. Objectives: This work represents a disruptive concept to modify natural hair colour and curvature. We aim to model the fibre phenotype as it is actively produced in the follicle through the topical delivery of specific bioactive molecules to the scalp. Methods: Transcriptome differences between curly and straight hairs were identified by microarray. In scalp samples, the most variable transcripts were mapped by in situ hybridization. Then, by using appropriate cellular models, we screened a chemical library of 1200 generic drugs, searching for molecules that could lead to changes in either fibre colour or curvature. A pilot-scale, single-centre, investigator- initiated, prospective, blind, bilateral (split-scalp) placebo-controlled clinical study with the intervention of cosmetics was conducted to obtain a proof of concept (RNEC n.92938). Results: We found 85 genes transcribed significantly different between curly and straight hair, not previously associated with this human trait. Next, we mapped some of the most variable genes to the inner root sheath of follicles, reinforcing the role of this cell layer in fibre shape moulding. From the drug library screening, we selected 3 and 4 hits as modulators of melanin synthesis and gene transcription, respectively, to be further tested in 33 volunteers. The intentional specific hair change occurred: 8 of 14 volunteers exhibited colour changes, and 16 of 19 volunteers presented curvature modifications, by the end of the study. Conclusion: The promising results obtained are the first step towards future cosmetics, complementary or alternative to current methodologies, taking hair styling to a new level: changing hair from the inside out. (c) 2024 The Authors. Published by Elsevier B.V. on behalf of Cairo University. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

7 April 2026 in International Journal of Pharmaceutics
Verified
Journal Article
Open access
CCC. Costa
C. Costa
Lucília P da SilvaLucília P da Silva
Lucília P da Silva
BFB. Fernandes
B. Fernandes
AFA.R. Franco
A.R. Franco
RRR.L. Reis
R.L. Reis
Alexandra P. MarquesAlexandra P. Marques
Alexandra P. Marques
Wound healing is complex and still requires targeted therapies and advanced dressings despite current advances. Honey (HNY) is a multifunctional bioactive agent with demonstrated benefits across various phases of healing. Here, we present a wound stage-specific formulation strategy that combines a previously uncharacterized multiflora HNY from Monte Novo (Portalegre, Portugal) with gellan gum (GG) to develop gels for osmolarity-driven debridement and hydrogels for sustained release of bioactive components post-debridement, thereby enhancing therapeutic outcomes. The amount of sugars and phenolic compounds in the HNY were consistent with its hyperosmotic nature and anti-oxidant and anti-microbial activity. Gels were prepared using 0.1 and 0.2% GG with 50-90% HNY to reduce HNY's inherent flowability and enhance retention at the wound site, while maintaining extrudability. Hydrogels were formulated with higher GG (0.75 and 1.25%) to form mechanically stable crosslinked networks, and lower HNY (10-40%) to reduce osmolarity while preserving bioactivity. All gel formulations were extrudable and demonstrated effective water absorption. Those with higher GG and lower HNY exhibited increased viscosity, required greater force to flow, and displayed solid-like behavior, favoring wound retention. The 80% HNY-0.2% GG formulation balanced viscosity and osmotic strength, as confirmed by cytotoxicity results, while preserving anti-microbial activity indicating suitability for wound debridement. Hydrogels showed increased stiffness with higher GG and HNY while maintaining HNY's bioactive constituents. The 30% HNY-1.25% GG formulation demonstrated superior stability and sustained release of HNY components, including phenolic compounds at levels supporting anti-inflammatory and healing effects. Although initial HNY hydrogel exposure reduced cell metabolic activity, cells recovered over time, maintaining proliferation and migratory function. Collectively, these findings highlight the potential of GG/HNY gel/hydrogel formulations to support wound management across different healing stages, offering effective debridement through osmotic action and prolonged therapeutic support via controlled bioactive components release.